First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.
Saved in:
| Title: | First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial. |
|---|---|
| Authors: | Hainsworth JD; The Sarah Cannon Cancer Center and Tennessee Oncology, Nashville, 37203, USA. jhainsworth@tnonc.com, Litchy S, Lamb MR, Rodriguez GI, Scroggin C Jr, Greco FA |
| Source: | Clinical lymphoma [Clin Lymphoma] 2003 Jun; Vol. 4 (1), pp. 36-42. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cancer Information Group Country of Publication: United States NLM ID: 100898741 Publication Model: Print Cited Medium: Print ISSN: 1526-9655 (Print) Linking ISSN: 15269655 NLM ISO Abbreviation: Clin Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
